生命科學(xué)與技術(shù)學(xué)院
教 案 首 頁
教研室:藥理學(xué) 教師姓名:歐和生
課 程名 稱 | 藥理學(xué) | 授課專業(yè)及班次 | 臨床醫(yī)學(xué)專業(yè) |
授課內(nèi) 容 | 腎素-血管緊張素系統(tǒng)藥理 | 授課方式 授課時數(shù) | 理論講授 2學(xué)時 |
目 的 要 求 | 1. 熟悉腎素-血管緊張素系統(tǒng)對心血管系統(tǒng)的生理機(jī)制。 | ||
重 點(diǎn) 與 難 點(diǎn) | 重點(diǎn) 1. ACEI和血管緊張素II受體I型阻滯劑的藥理作用及其機(jī)制。 2. 托普利和氯沙坦等藥物的藥理作用、臨床應(yīng)用。 難點(diǎn) 腎素-血管緊張素系統(tǒng)對心血管系統(tǒng)調(diào)節(jié)的生理機(jī)制及藥物作用機(jī)制。 | ||
授課內(nèi)容及時間分配 | 1. Renin-Aangiotensin-System (20 分鐘) 2. Angiotensin converting enzyme inhibitors (ACEI) (45分鐘) 3. The blockade of angiotension II receptor (20 分鐘) 4. 小結(jié)、布置思考題、安排下次課內(nèi)容 (5分鐘) | ||
教具教材 | 多媒體加版書 教材:楊寶峰 主編:藥理學(xué) 人民衛(wèi)生出版社,北京,2003年 | ||
參 考 書 及 網(wǎng) 站 | 1. 周宏灝主編:藥理學(xué) 科學(xué)出版社,北京,2003年 2. Pharmacology : 天津醫(yī)科大學(xué)藥理教研室主編,1999年 3. H.P. Rang, M.M Dale, J.M. Ritter P.K. Moore. Pharmacology ( the fifth edition). 2003. |
Part 1 Renin-Aangiotensin-System
Introduction
1.Element of RAS (renin, angiotensinogen,angiotensin, ACE, ATR)
Renin is an enzyme that acts on angiotensinogen to catalyze the formation of the decapeptide angiotensin I.
Angiotensin I is then cleaved by ACE to yield the octapeptide angiotensin II.
ATR: AT1R, AT2R
2.The regulation effect of RAS on blood pressure
The renin-angiotensinsystem is an important participant in both the short-and long-term regulationof arterial blood pressure.
Angiotensin II acts in several ways to increase totalperipheral resistance and thereby contributes to the short-term regulation ofarterial blood pressure. Perhaps the more important is the ability of angiotensin II to inhibit excretion of Na+ and water by thekidneys.
Angiotensin II – induced changes in renal functionplay an important role in long-term stabilization of arterial blood pressure.
Part 2 Angiotensinconverting enzyme inhibitors (ACEI)
1.Pharmacological effects
(1) Inhibit the formation of Ang II.
(2) Maintain the activity of brandykinin (BK).
(3) Protection of endothelium andanti-atherosclerosis
(4) Anti-iscamiaand protection of myocardial cell
(5) Increase the sensitivity of insulin
(6) Inhibit the pathological cardiovascular remodeling
2. Clinical uses
(1) Hypertension
(2) CHF and myocardial infarction
(3) DMEM and nephropathy
3. Untoward effects
(1) Hypotension: occurring in the first use.
(2) Cough: of 6 ~ 12%
(3) Hyperkalemia
(4) Low blood sugar
(5) Renal function trauma
(6) Affection of the development of fetus and newborn.
(7) Neuro Oedema.
(8) Malfunction of taste, tetter (thedrugs with –SH).
4.The drugs of ACEI.
. Captopril
Pharmacological Action :
i Directly inhibited ACE. (IC50:23 ~ 35 nmol /L), The depressor effect associated with the activitystate of RAS.
ii The protection of heart is relatedto abolishing of ROS, such as iscamia.
Pharmacokinetics
o Absorption : Po, F=75%. Taction :30 min. Tmax=1h.
o Distribution: extensivelydistributed in body , Pb=30%.
o Metabolism: oxygen in –SH.
o Excretion: from kidney: 40-50%in parent drug and the others in metabolites.
o Hypertension: single or combination.
o CHF
o Cardiac infarct.
o DMEM-nephropathy (only captopril).
Untoward effects
Apart fromthe common side effect, cough is usually complaint.
Enalapril
o Action : the action of inhibition of ACE is 10 times stronger than captopril.
o The absorption is not affectedby food. Po. TP=4-6h. Tmaintain=24h,q.d.
o Metabolism: enalaprilat(MK22)
o Distribution extensively inbody. T1/2: 11h.
o Excretion from kidney.
o Uses: hypertensionbhskgw.cn/sanji/ and CHF.
o Aside effect: cough ,hypotension, hyperkalemiaetc.
Fosinopril
o Prodrug (poo-): fosinoprilacid is the activity chemical.
o Tp=3-6 h
o Pb=95%
o&bhskgw.cn/kuaiji/nbsp; T1/2=12h
o Distribution : heart and brain(much)
o Excretion: from liver and kidney, no toxicityaccumulation for light malfunction of kidney.
o No use:lactation
Lisinopril
benazepril
Part 3 The blockade of angiotension II receptor
losartan、valsartan、erbesartan、candesartan、tasosartan、eprosartan、telmisartan
1. Pharmacological effects and mechanism
(1) Block the AT1R vasodilatation
Aldostrone Hypotension
(2) Block theAT1R Renin AngII AT2RBK-NO
Vasodilatation, regression of remodeling Hypotension.
Losartan
(1)AT1R: Losartan block AT1R>AT2R (2-3萬倍). EXP3174 >losartanin blocking AT1R (10- 40 times)
(2)Vasodilate renalartery, decrease reabsorption of water and Na+in renal tube.
(3)Protect kidney:Hypertension,DM and failure of kidney.
(4)Inhibit vascular remodeling.
(1) Hypertension
(2)CHF
Part 4 Howabout combination of AT1Ranta and ACEI
1. Increase effects(cure in hypertension, CHF), decrease disadvantage of the two class drugs.
2. Have not found anyadverse effects
Questions:
1. Describe the advantages anddisadvantages of AT1R and ACEI in therapeutics of hypertension.
2. what is thecommon side effect of Captopril?